Skip to main content

Table 5 Published patents on CM epigeneticsa

From: Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies

TITLE

PATENT NUMBER

PUBLICATION DATE

ADMINISTRATION OF AN INHIBITOR OF HDAC AND AN HMT INHIBITOR

WO2009126537

15/10/2009

USE OF METHYLATION STATUS OF MINT LOCI AND TUMOR-RELATED GENES AS A MARKER FOR MELANOMA AND BREAST CANCER

WO2009086472

09/07/2009

GENE METHYLATION IN DIAGNOSIS OF MELANOMA

US2009170083

02/07/2009

ADMINISTRATION OF AN INHIBITOR OF HDAC

WO2009067500

28/05/2009

MARKERS FOR MELANOMA

US2009093424

09/04/2009

USE OF HDAC INHIBITORS FOR THE TREATMENT OF MELANOMA

CA2684114

20/11/2008

UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIAGNOSIS AND TREATMENT OF CANCER

WO2008121125

09/10/2008

INHIBITORS OF DNA METHYLATION IN TUMOR CELLS

US2008138329

12/06/2008

METHODS AND PRODUCTS FOR DIAGNOSING CANCER

WO2008066878

05/06/2008

UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIAGNOSIS AND TREATMENT OF CANCER

WO2007123697

01/11/2007

MARKERS FOR MELANOMA

EP1840227

03/10/2007

MARKERS FOR MELANOMA

WO2006092610

08/09/2006

COMBINED USE OF PRAME INHIBITORS AND HDAC INHIBITORS

CA2553886

18/08/2005

USE OF BAGE (B MELANOMA ANTIGENS) LOCI AS TUMOUR MARKERS

WO2004101822

25/11/2004

  1. a, as retrieved from database search on: http://ep.espacenet.com